Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 08, 2020

SELL
$4.41 - $9.28 $418,950 - $881,599
-95,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$1.45 - $6.73 $137,750 - $639,350
95,000 New
95,000 $544,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $44.7M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Quilter PLC Portfolio

Follow Quilter PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quilter PLC, based on Form 13F filings with the SEC.

News

Stay updated on Quilter PLC with notifications on news.